Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterosubtypic immune responses to H5N1 and seasonal influenza vaccines in adults
ISRCTN70837239Phase 2Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Aug 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label, single-arm trial of Butantan Influenza Trivalent, Fragmented and Inactivated in influenza, sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Antibody titres and mean fold rise, Seroconversion rate and 1 more. Started Aug 2009; status: completed.
02
Drugs
Butantan Influenza Trivalent, Fragmented and Inactivated
03
Conditions
influenza
Beyond the preview
Go deeper on ISRCTN70837239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70837239.